Patent · US Active

Bispecific antibodies specific for OX40

US12240911B2 · kind B2 · utility

0Cited by
47References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 14, 2019
Grant dateMar 4, 2025
Priority date
Expiry dateNov 27, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to novel bispecific antigen binding molecules, comprising (a) at least one moiety capable of specific binding to a target cell antigen, (b) at least one moiety capable of specific binding to a costimulatory TNF receptor family member, and (c) a Fc domain composed of a first and a second subunit capable of stable association, and to methods of producing these molecules and to methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.